More directly, Ji et al. [21] reported that the hepatitis B core VLP-based mis-disordered tau vaccine alleviated cognitive deficits and neuropathology progression in a Tau.P301S mouse model of Alzheimer’s disease. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.